NPPNY
NIPPON SHINYAKU CO., LTD. ADR CMN (NPPNY) [OT]
NIPPON SHINYAKU UNSP/ADR
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
-1
0 buys · 1 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-02-27 | NPPNYNIPPON SHINYAKU CO., LTD. ADR CMN (NPPNY) [OT] | Sell | $1,001 - $15,000 | 1310d ago | — |
2023-02-27
Daniel Goldman
NPPNY
Amount
$1,001 - $15,000
Filed
1310d ago
Recent News
Powered by Polygon.io
AB2 Bio receives $30 million from Nippon Shinyaku for exclusive U.S. commercialization rights to Tadekinig Alfa
Duchenne Muscular Dystrophy Market to Witness Significant Expansion During the Forecast Period (2025–2034) Amidst Advances in Gene Therapy and Novel Drug Approvals | DelveInsight
AB2 Bio signs U.S. option and licensing agreement with Nippon Shinyaku for Tadekinig alfa for an ultra-rare autoimmune disease
Nippon Shinyaku and Atsena Therapeutics enter into an Exclusive Strategic Collaboration for ATSN-101 in the U.S. and Japan
Retinoblastoma Treatment Market to Surpass $2 Billion in 2024, Exhibiting a CAGR of 5.5% - Global Long-term Forecasts to 2028 and 2033
Trade Timeline
Congressional activity, newest first
Daniel Goldman
2023-02-27 · Sale
$1,001 - $15,000